5 documents found, page 1 of 1
Prevalence and factors associated with SARS-CoV-2 infection: a serial populatio...
Cardoso, Orlei Amaral; Gomes, Cristiana Costa; Cerutti Junior, Crispim; Maciel, Ethel Leonor Noia; Alencar, Filomena Euridice Carvalho deObjective: To analyze the seroprevalence of SARS-CoV-2 and the association of sociodemographic and clinical aspects in the state of Espírito Santo, Brazil. Methods: Serial cross-sectional study carried out in four phases, using households as the unit of analysis, from May to June 2020. 11 municipalities were surveyed, with a sample of 4,500 households in each phase. Results: the prevalence ranged from 2.1% (95%...
Covid-19 in subnormal and non-subnormal cluster areas in Espírito Santo, Brazil
Maciel, Ethel; Jabor , Pablo Medeiros; Macedo, Laylla Ribeiro; Almada, Gilton Luiz; Zanotti , Raphael Lubiana; Cerutti Junior , CrispimObjectives: to estimate the prevalence of SARS-CoV-2 infection in residents of the Greater Vitória region living in subnormal and non-subnormal agglomerations; and, compare sociodemographic and clinical characteristics of total residents (infected and not infected with SARS-CoV-2), among these clusters. Method: Population-based prevalence study, through serological testing carried out in 2020, with a study unit...
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naive adults with ...
Peribanez-Gonzaleza, Mario; Cheinquer, Hugo; Rodrigues, Lino; Lima, Maria Patelli; Alvares-da-Silva, Mario Reis; Madruga, Jose; Parise, Edison RobertoMade available in DSpace on 2021-06-25T15:08:07Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01; AbbVie; Introduction and objectives: Glecaprevir/pibrentasvir is a highly effective and well tolerated treatment for hepatitis C infection. Brazilian patients were not included in the original development studies for glecaprevir/pibrentasvir. This study aimed to assess safety and efficacy of glecaprevir...
HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE
Castelo, Adauto; Mello, Carlos Eduardo BrandÃo; Teixeira, Rosangela; Madruga, Jose Valdez Ramalho; Reuter, Tania; Pereira, Leila Maria Moreira BeltrãoMade available in DSpace on 2019-10-03T17:31:13Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-12-01. Added 1 bitstream(s) on 2019-10-04T16:20:23Z : No. of bitstreams: 1 S0004-28032018002400329.pdf: 264375 bytes, checksum: a057596e119e73acaf2321d69db282bd (MD5); RESUMOCONTEXTO:A infecção pelo vírus da hepatite C (HCV) é uma das principais causas de hepatite C crônica e provoca implicações graves para pa...
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibi...
Cahn, Pedro; Pozniak, Anton L.; Mingrone, Horacio; Shuldyakov, Andrey; Brites, Carlos; Andrade-Villanueva, Jaime F.; Richmond, GaryTexto completo. Acesso restrito. p. 700–708; Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-10-09T18:43:26Z No. of bitstreams: 1 3333.pdf: 353833 bytes, checksum: dec6effec957eb30783b421ac6047738 (MD5); Approved for entry into archive by Rodrigo Meirelles (rodrigomei@ufba.br) on 2013-11-03T14:24:32Z (GMT) No. of bitstreams: 1 3333.pdf: 353833 bytes, checksum: dec6effec957eb30783b421ac6047738 ...